Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted bet...

por Ossato, Andrea, Tessari, Roberto, Trabucchi, Carlotta, Zuppini, Teresa, Realdon, Nicola, Marchesini, Francesca
Publicado 2023

How to improve TB outpatient service in a TB low-endemic country during SARS-CoV-2 pandemic

por RICCARDI, NICCOLÒ, RODARI, PAOLA, DURANTI, SILVIA, VILLA, SIMONE, ASSANTE, LUCA ROSARIO, CASTELLOTTI, PAOLA, FERRARESE, MAURIZIO, MARTINI, MARIANO, ZUPPINI, TERESA, TESSARI, ROBERTO, CALZA, CRISTINA, CODECASA, LUIGI, BESOZZI, GIORGIO, ANGHEBEN, ANDREA
Publicado 2021

High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial

por Buonfrate, Dora, Chesini, Fabio, Martini, Davide, Roncaglioni, Maria Carla, Ojeda Fernandez, Maria Luisa, Alvisi, Maria Francesca, De Simone, Irene, Rulli, Eliana, Nobili, Alessandro, Casalini, Giacomo, Antinori, Spinello, Gobbi, Marco, Campoli, Caterina, Deiana, Michela, Pomari, Elena, Lunardi, Gianluigi, Tessari, Roberto, Bisoffi, Zeno
Publicado 2022